Quantcast

Latest Nosocomial infection Stories

2014-09-15 23:01:28

Ondine's President and Chief Technology Officer Dr. Nicolas Loebel will be presenting at the 10th International Symposium on Photodynamic Therapy & Photodiagnosis in Clinical Practice Vancouver, BC (PRWEB) September 15, 2014 Ondine Biomedical Inc. is pleased to announce that Dr. Nicolas Loebel, its President and Chief Technology Officer, will be presenting at the 10th International Symposium on Photodynamic Therapy (PDT) and Photodiagnosis in Clinical Practice. The 2014 Symposium,...

2014-09-12 16:24:11

DUBLIN, September 12, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fqhgtd/pipeline_analysis) has announced the addition of the "Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Trends and Forecast to 2020" [http://www.researchandmarkets.com/research/fqhgtd/pipeline_analysis ] report to their offering....

2014-09-08 12:25:06

ALBANY, New York, September 8, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" six phase III drugs would generate total revenue of USD 3.8 billion by 2020. Browse the...

2014-09-05 23:06:22

Prime Medical Apparel is giving medical professionals, patients and the public added protection against Healthcare-associated Infections (HAI). Tampa, Florida (PRWEB) September 05, 2014 Prime Medical Apparel (PMA), a new company committed to changing the medical soft surface industry, is pleased to announce the upcoming launch of its new line of antimicrobial soft surfaces medical apparel and products. Made from an innovative and patented fabric technology to provide a protective barrier...

2014-09-04 23:10:55

Significant Surgical Site Infection Reduction Demonstrated Vancouver, Canada (PRWEB) September 04, 2014 Results of the first large-scale deployment of Ondine Biomedical’s MRSAid™ Nasal Photodisinfection System demonstrating reduction of surgical site infection rates have been published in the Journal of Hospital Infection (http://www.journalofhospitalinfection.com/article/S0195-6701(14)00224-2/abstract ).    The system was deployed at The Vancouver General...

2014-09-03 12:23:00

WASHINGTON, Sept. 3, 2014 /PRNewswire-USNewswire/ -- An advisory committee to the Food and Drug Administration was told that unreasonable FDA restrictions on healthcare use of safe and effective antibacterial ingredients could jeopardize the safety of patients and healthcare workers alike. http://photos.prnewswire.com/prnvar/20140313/DC83006LOGO In a presentation to FDA's Nonprescription Drugs Advisory Committee (NDAC) organized by the American Cleaning Institute (ACI), health...

2014-08-26 23:04:08

Transparency Market Research published a new report "U.S. Antimicrobial Plastics Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Albany, New York (PRWEB) August 26, 2014 Antimicrobial Plastics Market was valued at USD 662.3 million in 2013 and is anticipated to reach USD 1,227.4 million by 2020, expanding at a CAGR of 9.3% during the forecast period from 2014 to 2020. In terms of volume, the antimicrobial plastics market in...

2014-08-26 08:30:26

SANTA ROSA, Calif., Aug. 26, 2014 /PRNewswire/ -- Ruthigen Inc. (NASDAQ: RTGN), a biopharmaceutical company focused on improving patient outcomes and reducing healthcare costs in invasive procedures, has announced that its lead drug candidate, RUT58-60, has received a recommendation from the Data Monitoring Committee (DMC) to begin enrolling patients in the Company's planned Phase 1/2 clinical trial. RUT58-60 is intended for use as an adjunct therapy in combination with prophylactic...

2014-08-13 08:27:19

NEW YORK, Aug. 13, 2014 /PRNewswire/ -- Antibiotic drug resistance is considered to play a part in 75,000 hospital acquired infection (HAI) deaths per year in the U.S., according to recent analysis by Kalorama Information. The healthcare market research publisher found that drug resistance is becoming more of an issue across the entire anti-infective continuum, despite indications that screening patients in the hospital would help to identify those patients that may be carriers of...

2014-08-01 08:26:36

UV disinfection device is game-changer for patients and hospital leaders alike MEMPHIS, Tenn., Aug. 1, 2014 /PRNewswire/ -- Healthcare-associated infections like Methicillin-Resistant Staphylococcus aureus, a bacterium that can cause life-threatening bloodstream infections, pneumonia and surgical site infections, are putting more than patient lives at risk every single day. They're also poised to take big bites out of hospital budgets across the country - to the tune of millions -...


Latest Nosocomial infection Reference Libraries

69_6c18294b6ad5d3bd2a21fde1a9e1ea03
2011-04-14 13:29:59

Acinetobacter baumannii is a species of pathogenic bacteria that is resistant to most antibiotics. Some think the disease is killing tens of thousands of U.S. hospital patients each year due to its resistance to drug treatment. It can cause severe pneumonia and infections of the urinary tract, bloodstream, and other parts of the body. It forms opportunistic infections including reports of attacking wounded soldiers and is sometimes abbreviated as MDRAB. It is the most relevant human...

More Articles (1 articles) »
Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.